Guided Therapeutics Inc (GTHP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Guided Therapeutics Inc (GTHP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6582
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-invasive cancer detection product. GTI develops technology to painlessly detect disease before it becomes cancer. The company’s LuViva advanced cervical scan product is a non-invasive device used to detect cervical disease instantly at the point of care. It markets its products across Canada, Mexico, Russia, Egypt, Libya, Malaysia, Indonesia, South Korea, Sudan, Uganda, Finland, Italy and the UK, among others. GTI is headquartered in Norcross, Georgia, the US.

Guided Therapeutics Inc (GTHP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guided Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guided Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guided Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Shandong Yaohua Medical Enters into Licensing Agreement with Guided Therapeutics 10
Guided Therapeutics Enters into Licensing Agreement for LuViva 11
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 12
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 13
ITEM Medical Enters into Licensing Agreement with Guided Therapeutics 14
Shenghuo Medical Enters into Licensing Agreement with Guided Therapeutics for LuViva 15
Equity Offering 16
Guided Therapeutics Raises USD1.3 Million in First Tranche of Private Placement of Shares 16
Guided Therapeutics Raises USD0.7 Million in Private Placement of Shares 17
Guided Therapeutics Raises USD0.2 Million in Private Placement of Shares 18
Guided Therapeutics Completes Private Placement Of Shares And Warrants For US$2.5 Million 19
Guided Therapeutics Completes Private Placement Of Shares For US$1.6 Million Upon Exercise Of Warrants 20
Debt Offering 21
Guided Therapeutics Raises USD0.16 Million in Private Placement of 12% Convertible Note 21
Guided Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes 22
Guided Therapeutics Inc – Key Competitors 23
Guided Therapeutics Inc – Key Employees 24
Guided Therapeutics Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Other Significant Developments 26
Jun 21, 2018: Guided Therapeutics Provides Progress Update on International Activities 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Guided Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guided Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guided Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shandong Yaohua Medical Enters into Licensing Agreement with Guided Therapeutics 10
Guided Therapeutics Enters into Licensing Agreement for LuViva 11
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 12
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 13
ITEM Medical Enters into Licensing Agreement with Guided Therapeutics 14
Shenghuo Medical Enters into Licensing Agreement with Guided Therapeutics for LuViva 15
Guided Therapeutics Raises USD1.3 Million in First Tranche of Private Placement of Shares 16
Guided Therapeutics Raises USD0.7 Million in Private Placement of Shares 17
Guided Therapeutics Raises USD0.2 Million in Private Placement of Shares 18
Guided Therapeutics Completes Private Placement Of Shares And Warrants For US$2.5 Million 19
Guided Therapeutics Completes Private Placement Of Shares For US$1.6 Million Upon Exercise Of Warrants 20
Guided Therapeutics Raises USD0.16 Million in Private Placement of 12% Convertible Note 21
Guided Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes 22
Guided Therapeutics Inc, Key Competitors 23
Guided Therapeutics Inc, Key Employees 24

List of Figures
Guided Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guided Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guided Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guided Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Guided Therapeutics Inc (GTHP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratoires Pierre Fabre SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務分析
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Visaka Industries Ltd:企業の戦略・SWOT・財務情報
    Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Purdue Pharma Canada-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • Armanino Foods of Distinction Inc.:企業の戦略・SWOT・財務情報
    Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report Summary Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nisshin Seifun Group Inc:戦略・SWOT・企業財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Unigroup Inc
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Shanghai Pharmaceutical Co Ltd (601607)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. It carries out the research and development, manufacture and sale of pharmaceutical products for treating cancer, central nervous system (CNS) disorders and diseas …
  • Sunbelt Transformer Ltd:電力:M&Aディール及び事業提携情報
    Summary Sunbelt Transformer Ltd (Sunbelt Transformer) is a provider of new and reconditioned transformers and electrical equipment for commercial and industrial markets. The company’s products include padmount transformers, substation transformers, dry-type transformers, pole-mount transformers, mot …
  • CytoSorbents Corp (CTSO):企業の財務・戦略的SWOT分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Medicines for Malaria Venture:企業のM&A・事業提携・投資動向
    Medicines for Malaria Venture - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medicines for Malaria Venture Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Avalon Oil & Gas Inc (AOGN):企業の財務・戦略的SWOT分析
    Summary Avalon Oil & Gas Inc (Avalon), is an oil and gas company that develops and operates crude oil and natural gas properties. The company acquires, produces and develops oil and natural gas reserves. It offers reservoir maintenance and technologies to produce portfolio of oil and gas leases in t …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • TauRx Pharmaceuticals Ltd:医療機器:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • Sumi-Eagle Corp:企業の戦略的SWOT分析
    Sumi-Eagle Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dassault Systemes SE (DSY):企業の財務・戦略的SWOT分析
    Dassault Systemes SE (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Terna SpA (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Terna S.p.A. (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers spec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆